BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7319909)

  • 1. Trisarubicinol, new antitumor anthracycline antibiotic.
    Yoshimoto A; Matsuzawa Y; Matsushita Y; Oki T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Nov; 34(11):1492-4. PubMed ID: 7319909
    [No Abstract]   [Full Text] [Related]  

  • 2. 13-Deoxycarminomycin, a new biosynthetic anthracycline.
    Cassinelli G; Forenza S; Rivola G; Arcamone F; Grein A; Merli S; Casazza AM
    J Nat Prod; 1985; 48(3):435-9. PubMed ID: 3861771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant.
    Yoshimoto A; Johdo O; Tone H; Okamoto R; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1992 Oct; 45(10):1609-17. PubMed ID: 1473988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and biological evaluation of 4-O-demethyldaunorubicin (carminomycin I) and of its 13-dihydro derivative.
    Cassinelli G; Grein A; Masi P; Suarato A; Bernardi L; Arcamone F; Di Marco A; Casazza AM; Pratesi G; Soranzo C
    J Antibiot (Tokyo); 1978 Mar; 31(3):178-84. PubMed ID: 649513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. II. New anthracycline metabolites produced by a blocked mutant strain RPM-5.
    Yoshimoto A; Fujii S; Johdo O; Kubo K; Nishida H; Okamoto R; Takeuchi T
    J Antibiot (Tokyo); 1993 Jan; 46(1):56-64. PubMed ID: 8436560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of new anthracyclines 10-O-rhodosaminyl beta-rhodomycinone and beta-isorhodomycinone from mild-acid treated culture of obelmycin-producing Streptomyces violaceus.
    Johdo O; Yoshioka T; Takeuchi T; Yoshimoto A
    J Antibiot (Tokyo); 1997 Jun; 50(6):522-5. PubMed ID: 9268010
    [No Abstract]   [Full Text] [Related]  

  • 7. A new anthracycline metabolite D788-1 (10-carboxy-13-deoxocarminomycin) in daunorubicin beer.
    Fujii S; Kubo K; Johdo O; Yoshimoto A; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Mar; 39(3):473-5. PubMed ID: 3700249
    [No Abstract]   [Full Text] [Related]  

  • 8. New antitumor antibiotics: 13-methylaclacinomycin A and its derivatives.
    Soga K; Furusho H; Mori S; Oki T
    J Antibiot (Tokyo); 1981 Jun; 34(6):770-3. PubMed ID: 6944303
    [No Abstract]   [Full Text] [Related]  

  • 9. Kazusamycin B, a novel antitumor antibiotic.
    Funaishi K; Kawamura K; Sugiura Y; Nakahori N; Yoshida E; Okanishi M; Umezawa I; Funayama S; Komiyama K
    J Antibiot (Tokyo); 1987 Jun; 40(6):778-85. PubMed ID: 3610834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neothramycins A and B, new antitumor antibiotics.
    Takeuchi T; Miyamoto T; Ishizuka M; Naganawa H; Kondo S
    J Antibiot (Tokyo); 1976 Jan; 29(1):93-6. PubMed ID: 931797
    [No Abstract]   [Full Text] [Related]  

  • 11. Chrolactomycin, a novel antitumor antibiotic produced by Streptomyces sp.
    Nakai R; Kakita S; Asai A; Chiba S; Akinaga S; Mizukami T; Yamashita Y
    J Antibiot (Tokyo); 2001 Oct; 54(10):836-9. PubMed ID: 11776440
    [No Abstract]   [Full Text] [Related]  

  • 12. Lavanducyanin, a new antitumor substance produced by Streptomyces sp.
    Imai S; Furihata K; Hayakawa Y; Noguchi T; Seto H
    J Antibiot (Tokyo); 1989 Jul; 42(7):1196-8. PubMed ID: 2753825
    [No Abstract]   [Full Text] [Related]  

  • 13. Porothramycin, a new antibiotic of the anthramycin group: production, isolation, structure and biological activity.
    Tsunakawa M; Kamei H; Konishi M; Miyaki T; Oki T; Kawaguchi H
    J Antibiot (Tokyo); 1988 Oct; 41(10):1366-73. PubMed ID: 3192492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracycline metabolites from Streptomyces violaceus A262. IV. New anthracycline yellamycins produced by a variant strain SC-7.
    Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1155-9. PubMed ID: 1955397
    [No Abstract]   [Full Text] [Related]  

  • 15. New antitumor antibiotic, FR-900462. II. Production, isolation, characterization and biological activity.
    Iwami M; Nakayama O; Okuhara M; Terano H; Kohsaka M
    J Antibiot (Tokyo); 1989 May; 42(5):686-90. PubMed ID: 2722682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new anthracycline antibiotic SN-706.
    Kimura K; Koyama T; Nakayama S; Tamura K; Miyata N; Kawanishi G
    J Antibiot (Tokyo); 1988 Dec; 41(12):1918-21. PubMed ID: 3209485
    [No Abstract]   [Full Text] [Related]  

  • 17. Anthracycline metabolites from Streptomyces violaceus A262. V. New anthracycline alldimycin A: a minor component isolated from obelmycin beer.
    Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1160-4. PubMed ID: 1955398
    [No Abstract]   [Full Text] [Related]  

  • 18. Protactin, a new antibiotic metabolite and a possible precursor of the actinomycins.
    Hanada M; Sugawara K; Nishiyama Y; Kamei H; Hatori M; Konishi M
    J Antibiot (Tokyo); 1992 Jan; 45(1):20-8. PubMed ID: 1372309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of new anthracycline antibiotic betaclamycin B by microbial conversion with a specific aclacinomycin-negative mutant.
    Yoshimoto A; Johdo O; Watanabe Y; Nishida H; Okamoto R; Takeuchi T
    J Antibiot (Tokyo); 1992 Jun; 45(6):1005-7. PubMed ID: 1500340
    [No Abstract]   [Full Text] [Related]  

  • 20. Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism.
    Yoshimoto A; Fujii S; Johdo O; Kubo K; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Jul; 39(7):902-9. PubMed ID: 3759649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.